Yes, ivermectin is an effective treatment for mange. It works against both major types of mange in dogs, treats notoedric mange in cats, and is used off-label for human scabies. The drug paralyzes and kills mange mites by flooding their nerve cells with chloride ions, which disrupts their nervous system in a way that doesn’t affect mammals at standard doses. That said, newer medications have largely replaced ivermectin as the first-choice option for many veterinarians, and certain dog breeds face serious risks from the drug.
How Ivermectin Kills Mange Mites
Ivermectin binds to specific ion channels found only in invertebrates, forcing those channels open and allowing chloride ions to rush into the mite’s nerve and muscle cells. This causes irreversible paralysis and death. The reason it’s safe for most mammals is that their version of these channels sits behind the blood-brain barrier, which ivermectin doesn’t easily cross. The result is a drug that’s lethal to mites at doses that cause no noticeable effects in most dogs, cats, and humans.
Sarcoptic Mange in Dogs
Sarcoptic mange, caused by the burrowing mite Sarcoptes scabiei, responds well to ivermectin. The standard veterinary protocol calls for a dose of 200 micrograms per kilogram of body weight, given orally or by injection, repeated every two weeks for two to four treatments total. This regimen is usually curative.
In clinical studies, a single ivermectin treatment achieved about 95% mite elimination by day 14, with full parasitological cure typically following the second dose. Itching tends to drop quickly once the mites die, but skin healing and hair regrowth take longer. Some dogs regrow their coat in four to six weeks, while others with more severe damage can take 12 weeks or more to look normal again.
Demodectic Mange in Dogs
Demodectic mange, caused by Demodex mites that live in hair follicles, is harder to treat. Unlike sarcoptic mange, generalized demodicosis requires daily oral ivermectin over a much longer period. In a study of dogs with treatment-resistant generalized demodicosis, 10 out of 12 were cured with daily ivermectin. The median treatment duration was 10 weeks, though some dogs needed up to five months.
Veterinarians typically monitor progress with skin scrapings every two to four weeks and continue treatment for at least two additional weeks after no mites are found. This extended timeline makes demodicosis significantly more demanding to treat than sarcoptic mange, and it’s one reason many vets now prefer newer alternatives for this form.
Mange in Cats
Cats most commonly develop notoedric mange, caused by Notoedres cati. Ivermectin at 200 micrograms per kilogram, given orally twice weekly for four doses (two weeks total), has shown complete clinical recovery in affected cats. Injections under the skin at the same dose have also been effective. No adverse reactions were reported in treated cats in published studies, and improvement was confirmed by the absence of mites on follow-up skin scrapings.
Human Scabies
Human scabies is essentially mange caused by a closely related mite. Oral ivermectin is widely used to treat it, though it is not FDA-approved for this purpose in the United States. The CDC recommends two doses of 200 micrograms per kilogram taken with food, spaced 7 to 14 days apart. The FDA-approved treatment for human scabies remains permethrin 5% cream, applied from the neck down and washed off after 8 to 14 hours. In practice, oral ivermectin is often preferred for crusted (severe) scabies or when topical treatment is impractical.
Breeds at Risk for Ivermectin Toxicity
Certain dog breeds carry a genetic mutation called MDR1 that prevents a key protein from keeping ivermectin out of the brain. In these dogs, the drug accumulates in the central nervous system and can cause life-threatening toxicity. The mutation was first identified in Collies in 1980 after cases of severe ivermectin poisoning, and it has since been found in Shetland Sheepdogs, Border Collies, Australian Shepherds, Old English Sheepdogs, English Shepherds, German Shepherds, White Swiss Shepherds, Miniature Shepherds, McNabs, Wällers, and Longhaired Whippets.
Dogs with two copies of the mutated gene are at highest risk and tend to develop the most severe symptoms. Dogs with a single copy may still react, though usually less severely. Genetic testing is available and takes the guesswork out of this entirely. If you have a herding breed or a mix that might carry herding breed genetics, testing before any ivermectin use is strongly recommended.
Signs of Ivermectin Toxicity
When ivermectin toxicity does occur, it primarily affects the nervous system. The most common signs are lethargy, loss of coordination (ataxia), excessive drooling, tremors, dilated pupils, and blindness. In severe cases, dogs can develop seizures, slip into a coma, or die. Because ivermectin has a long half-life in the body, these symptoms don’t resolve quickly. Recovery from an overdose can take days to weeks depending on the dose involved.
Newer Alternatives to Ivermectin
A class of drugs called isoxazolines has largely shifted how veterinarians approach mange treatment. These include fluralaner, sarolaner, and afoxolaner, which are the active ingredients in several common flea and tick chewables. For sarcoptic mange, these drugs match or exceed ivermectin’s effectiveness with a simpler dosing schedule and no reported side effects in clinical trials.
Fluralaner stands out for speed: a single oral dose cleared mites in all treated dogs by day 14 and resolved visible skin symptoms within 21 days. Sarolaner reached 100% efficacy by day 60 in a head-to-head comparison with a topical combination product that achieved 96%. Afoxolaner cured sarcoptic mange with two monthly doses. All of these isoxazolines achieved complete parasitological cure without the breed-specific toxicity risks that come with ivermectin.
Ivermectin remains a viable and very affordable option, particularly in settings where cost matters or newer drugs aren’t available. But for herding breeds, for owners who want a simpler treatment schedule, or when a veterinarian wants to avoid the prolonged daily dosing that demodicosis requires, isoxazolines have become the preferred choice.